Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings

Shares (Q2 2026)
3,494
Value
$428.3K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of PTGX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,494$428.3K<0.1%−420−10.7%ReducedHolders
Q1 20263,914$412.5K<0.1%−481−10.9%ReducedHolders
Q4 20254,395$383.9K<0.1%−1,457−24.9%ReducedHolders
Q3 20255,852$388.7K<0.1%+629+12.0%AddedHolders
Q2 20255,223$288.7K<0.1%+1,569+42.9%AddedHolders
Q1 20253,654$176.7K<0.1%+1,524+71.5%AddedHolders
Q4 20242,130$82.2K<0.1%−5,736−72.9%ReducedHolders
Q3 20247,866$354.0K<0.1%−701−8.2%ReducedHolders
Q2 20248,567$296.8K<0.1%+2,281+36.3%AddedHolders
Q1 20246,286$181.9K<0.1%−881−12.3%ReducedHolders
Q4 20237,167$164.3K<0.1%−2,743−27.7%ReducedHolders
Q3 20239,910$165.3K<0.1%+9,871+25,310.3%AddedHolders
Q2 202339$1.08K<0.1%+39NewHolders
Q4 20220$00.0%−1,112−100.0%Sold outHolders
Q3 20221,112$9.00K<0.1%+1,112NewHolders
Q2 20220$00.0%−470−100.0%Sold outHolders
Q1 2022470$11.0K<0.1%+192+69.1%AddedHolders
Q4 2021278$10.0K<0.1%+14+5.3%AddedHolders
Q3 2021264$4.00K<0.1%−91−25.6%ReducedHolders
Q2 2021355$16.0K<0.1%00.0%UnchangedHolders
Q1 2021355$9.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.